Table 4 Risk and cumulative incidence of CCS categories in the case vs. controls
CCS Condition with Time Period | Case Cumulative Incidence | Control Cumulative Incidence | Risk Ratio [95% CI] |
|---|---|---|---|
Total - Any condition | |||
Late | 26.1% | 25.2% | 1.04 [1.01,1.07] * |
Acute and persistent | 20.4% | 22.1% | 0.92 [0.89,0.95] * |
Pre-existing conditions | 46.1% | 44.2% | 1.04 [1.02,1.06] * |
Total - PASC related conditions | |||
Late | 13.6% | 12.1% | 1.12 [1.08,1.16] * |
Acute and persistent | 4.1% | 2.5% | 1.60 [1.48,1.72] * |
Pre-existing conditions | 30.7% | 29.0% | 1.06 [1.03,1.08] * |
Abdominal pain | |||
Late | 1.8% | 1.7% | 1.05 [0.95,1.17] |
Acute and persistent | 0.2% | 0.2% | 0.87 [0.63,1.20] |
Pre-existing conditions | 3.4% | 3.4% | 1.00 [0.93,1.07] |
Anosmia | |||
Late | 0.3% | 0.1% | 3.88 [2.79,5.40] * |
Acute and persistent | 0.0% | 0.0% | 0.50 [0.11,2.28] |
Pre-existing conditions | 0.0% | 0.0% | 1.25 [0.31,5.00] |
Anxiety disorders | |||
Late | 1.1% | 1.1% | 1.01 [0.89,1.15] |
Acute and persistent | 0.2% | 0.3% | 0.83 [0.63,1.10] |
Pre-existing conditions | 2.8% | 3.6% | 0.78 [0.72,0.84] * |
Cardiac dysrhythmias | |||
Late | 0.9% | 0.7% | 1.25 [1.08,1.45] * |
Acute and persistent | 0.3% | 0.2% | 1.90 [1.45,2.49] * |
Pre-existing conditions | 1.6% | 1.5% | 1.02 [0.91,1.14] |
Conditions associated with dizziness or vertigo | |||
Late | 1.7% | 1.6% | 1.05 [0.94,1.16] |
Acute and persistent | 0.2% | 0.2% | 1.08 [0.82,1.44] |
Pre-existing conditions | 3.6% | 3.4% | 1.04 [0.96,1.12] |
Diabetes | |||
Late | 0.9% | 0.8% | 1.20 [1.03,1.38] * |
Acute and persistent | 0.3% | 0.2% | 1.96 [1.50,2.55] * |
Pre-existing conditions | 11.5% | 9.3% | 1.23 [1.18,1.29] * |
Fluid and electrolyte disorders | |||
Late | 0.4% | 0.6% | 0.73 [0.59,0.90] * |
Acute and persistent | 0.2% | 0.1% | 1.96 [1.41,2.74] * |
Pre-existing conditions | 0.7% | 0.8% | 0.82 [0.69,0.97] * |
Genitourinary symptoms and ill-defined conditions | |||
Late | 1.5% | 1.2% | 1.21 [1.07,1.36] * |
Acute and persistent | 0.1% | 0.1% | 1.14 [0.75,1.74] |
Pre-existing conditions | 2.1% | 2.0% | 1.04 [0.94,1.14] |
Gastrointestinal Disease | |||
Late | 1.7% | 1.7% | 1.00 [0.90,1.12] |
Acute and persistent | 0.4% | 0.4% | 0.98 [0.79,1.21] |
Pre-existing conditions | 3.4% | 4.0% | 0.84 [0.78,0.90] * |
Malaise and fatigue | |||
Late | 1.4% | 0.9% | 1.60 [1.41,1.81] * |
Acute and persistent | 0.3% | 0.1% | 2.89 [2.10,3.98] * |
Pre-existing conditions | 1.0% | 0.9% | 1.15 [1.00,1.33] * |
Mental health | |||
Late | 1.1% | 1.2% | 0.95 [0.83,1.08] |
Acute and persistent | 0.2% | 0.3% | 0.62 [0.45,0.86] * |
Pre-existing conditions | 4.0% | 5.6% | 0.71 [0.67,0.76] * |
Nausea and vomiting | |||
Late | 0.7% | 0.7% | 0.95 [0.80,1.12] |
Acute and persistent | 0.1% | 0.1% | 0.81 [0.49,1.32] |
Pre-existing conditions | 0.6% | 0.7% | 0.84 [0.71,1.00] |
Nonspecific chest pain | |||
Late | 1.7% | 1.2% | 1.39 [1.24,1.55] * |
Acute and persistent | 0.4% | 0.2% | 2.39 [1.85,3.10] * |
Pre-existing conditions | 1.8% | 1.5% | 1.25 [1.12,1.39] * |
Other lower respiratory disease | |||
Late | 1.1% | 1.2% | 0.92 [0.80,1.04] |
Acute and persistent | 1.2% | 0.5% | 2.51 [2.15,2.92] * |
Pre-existing conditions | 12.2% | 10.0% | 1.21 [1.16,1.26] * |
Other nervous system disorders | |||
Late | 0.7% | 0.7% | 1.04 [0.89,1.22] |
Acute and persistent | 0.1% | 0.1% | 0.97 [0.64,1.49] |
Pre-existing conditions | 1.3% | 1.5% | 0.87 [0.77,0.98] * |
Other nutritional; endocrine; and metabolic disorders | |||
Late | 0.5% | 0.4% | 1.14 [0.93,1.40] |
Acute and persistent | 0.0% | 0.1% | 0.54 [0.30,0.99] * |
Pre-existing conditions | 0.4% | 0.4% | 0.82 [0.66,1.03] |
Respiratory failure; insufficiency; arrest (adult) | |||
Late | 0.1% | 0.1% | 1.14 [0.73,1.80] |
Acute and persistent | 0.7% | 0.0% | 22.95 [14.78,35.64] * |
Pre-existing conditions | 0.3% | 0.2% | 1.72 [1.29,2.29] * |
